Hepatology

doi: 10.25005/2074-0581-2017-19-3-303-307
SIGNIFICANCE OF IMMUNOSUPPRESSION AND ELASTOMETRY INDICES OF LIVER IN THE TACTICS OF HIV/HCV CO-INFECTION TREATMENT

E.R. Rakhmanov1, N.M. Gulyamova1, V.N. Tsoy1, Т.М. Sharipov2, O. Sayfuddinov3

1Department of Infectious Diseases, Avicenna Tajik State Medical University, Dushanbe, Tajikistan
2The Local Center for AIDS Control and Prevention, Dushanbe, Tajikistan
3Institute of Gastroenterology, Dushanbe, Tajikistan

Objective: Correction of the main treatment regimen for HIV/HCV co-infection, taking into account the degree of immunosuppression based on indices of CD4+ cells in 1 μl of blood and the severity of hepatic fibrosis tissue according to the elastometry of the liver.

Methods: A complex examination of 21 patients with HIV/HCV co-infection was carried out, according to anamnestic data who are the users of long-term injecting drugs. The diagnosis of HIV infection was confirmed by the positive result of the rapid test, ELISA, (enzyme-linked immunosorbent assay), immunoblotting. Hepatitis C virus is diagnosed by detection by ELISA of serum anti-HCV. To determine the degree of liver fibrosis, the method of elastometry on the FibroScan apparatus (France) was used on the basis of the Institute of Gastroenterology. The results were evaluated on a scale of the degree of fibrosis of liver METAVIR from F0 (healthy liver) to F4 (hepatic cirrhosis). The number of CD4+ lymphocytes in 1 μl of blood was determined by flow cytometry.

Results: With a targeted comprehensive examination of 21 patients with HIV/HCV co-infection, pronounced oscillations in the results of elastometry of the hepatic tissue (from F0 to F4), regardless of the number of CD4+ cells (24 to 809 cells/μl) were found.

Conclusions: The results obtained indicate that there is no direct correlation between the degree of immunosuppression in CD4+ indices and the process of formation of hepatic fibrosis in patients with co-infection with HIV/HCV, which is a significant additional diagnostic criterion in choosing the priority of therapy.

Keywords: Elastometry, immunosuppression, co-infection, HIV, HCV.

Download file:


References
  1. Rafiev HK, Nurov RM, Tursunov RA. VICH-infektsiya i virusnye gepatity sredi zaklyuchyonnykh [HIV infection and viral hepatitis among prisoners]. Vestnik Avitsenny [Avicenna Bulletin]. 2012;3:111-4.
  2. Tursunov RA. Koinfektsiya VICH i parenteral’nykh virusnykh gepatitov u narkozavisimykh [Coinfection with HIV and parenteral viral hepatitis in drug addicts]. Vestnik Avitsenny [Avicenna Bulletin]. 2012;2:182-9.
  3. Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. NEJM. 2013;368(20):1907-17.
  4. Rosen HR. Chronic hepatitis C infection. NEJM. 2011;364(25):2429-38.
  5. Arora S, Thornton K, Murata G. Outcomes of treatment for hepatitis C virus infection by primary care providers. NEJM. 2011;364(23):2199-207.
  6. Mirodzhov GK. Sovremennye puti usovershenstvovaniya lecheniya khronicheskogo gepatita C [The present time ways to improvement of treatment of chronic hepatitis С]. Izvestiya Akademii nauk Respubliki Tadzhikistan. Otdelenie biologicheskikh i meditsinskikh nauk. 2009;1:63-71.
  7. Belyakov NA, Rakhmanova AG. Virus immunodefitsita cheloveka –meditsina. Rukovodstvo. 2-e izdanie [Human immunodeficiency virus – medicine]. Saint Petersburg, RF: Baltiyskiy meditsinskiy obrazovatel’nyy tsentr; 2011. 656 p.
  8. Bartlett D, Gallant D, Fam P. Klinicheskie aspekty VICH-infektsii 2009-2010 [Medical management of HIV infection 2009-2010]. Moscow, RF: R.Valent; 2010. 490 p.
  9. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. NEJM. 2007; 356:1445- 54.
  10. Makhmanurov AA, Tursunov RA, Abdikerimov MM, Suvanbekov AA, Sattarova GJ. Osobennosti techeniya khronicheskogo virusnogo gepatita C u VICH-infitsirovannykh bol’nykh [Features of chronic hepatitis c currency in HIV-infected patients]. Vestnik Avitsenny [Avicenna Bulletin]. 2011;4:104-8.
  11. Mirodzhov GK, Avezov SA, Makhmadaliev SM, Tukhtaeva NS. Rasprostranyonnost’ tsirroza pecheni v Tadzhikistane [Prevalence of liver cirrhosis in Tajikistan]. Vestnik Avitsenny [Avicenna Bulletin]. 2012;2:112-5.
  12. Khoffman K, Rokshtro YuK. VICH 2014-2015 [HIV 2014-2015]. Berlin, Germany: Medizin Fokus; 2014. 924 p.
  13. Nunez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology. 2010;52:1143-55.
  14. Rukovodstvo po skriningu, okazaniyu pomoshchi i lecheniyu pri khronicheskoy infektsii, vyzvannoy virusom gepatita C. Rukovodstvo [Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection]. VOZ. Obnovlyonnaya versiya; 2016. 165 p.
  15. Vergara S, Macı´as J, Rivero A. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clinical Infectious Diseases. 2007;45:969-74.

Authors informations:

Rakhmanov Erkin Rakhimovich, Doctor of Medical Sciences, Full Professor, Head of the Department of Infectious Diseases of Avicenna TSMU

Gulyamova Nazira Minhodzhevna, Candidate of Medical Sciences, Assistant of the Department of Infectious Diseases of Avicenna TSMU

Tsoy Viktoria Nikolaevna, Assistant of the Department of Infectious Diseases of Avicenna TSMU

Sharipov Turakhon Mahmudovich, Candidate of Medical Sciences, Director of the Local Center for HIV/AIDS Prevention and Control

Sayfuddinov Obiddin, Physician of the Liver Elastometry Cabinet, Institute of Gastroenterology

Address for correspondence:

Rakhmanov Erkin Rakhimovich

Doctor of Medical Sciences, Full Professor, Head of the Department of Infectious Diseases of Avicenna TSMU

734003, Republic of Tajikistan, Dushanbe, Rudaki Ave., 139

Tel.: (+992) 951 916000

E-mail: erkin_rahmonov@mail.ru

Materials on the topic: